Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease - Satyam, Venkata R.; Li, Pei-Hsuan; Reich, Jason; Qazi, Taha; Noronha, Ansu; Wasan, Sharmeel K.; Farraye, Francis A. (Digestive diseases and sciences, 2020)
Keywords: Aged; Biochemistry; Colitis, Ulcerative - diagnosis; Colitis, Ulcerative - drug therapy; Colitis, Ulcerative - immunology; Complications and side effects; Crohn Disease - diagnosis; Crohn Disease - drug therapy; Crohn Disease - immunology; Crohn's disease; Development and progression; Disease Progression; Drug therapy; Female; Gastroenterology; Hepatology; Herpes Zoster - diagnosis; Herpes Zoster - immunology; Herpes Zoster - prevention & control; Herpes Zoster Vaccine - administration & dosage; Herpes Zoster Vaccine - adverse effects; Humans; Immunization; Immunization Schedule; Inflammatory bowel disease; Male; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Middle Aged; Oncology; Original Article; Prospective Studies; Risk Assessment; Risk Factors; Shingles (Disease); Time Factors; Tofacitinib; Transplant Surgery; Treatment Outcome; Ulcerative colitis; Vaccination; Vaccines; Vaccines, Synthetic - administration & dosage; Inflammatory bowel disease; Vaccine adjuvant; Herpes zoster; Vaccination; Crohn’s disease; Ulcerative colitis